P

Inventor

SCHWITTER URS

CH22 patents
⚠️ This page may combine multiple inventors who share the name “SCHWITTER URS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HOFFMANN LA ROCHE

18 patents
US11230559B2Jan 25, 2022

Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate

HOFFMANN LA ROCHE4 citations71
US11040977B2Jun 22, 2021

Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof

HOFFMANN LA ROCHE1 citations70
US10246460B2Apr 2, 2019

Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof

HOFFMANN LA ROCHE2 citations70
US9676793B2Jun 13, 2017

Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same

HOFFMANN LA ROCHE2 citations64
US12012421B2Jun 18, 2024

Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate

HOFFMANN LA ROCHE0 citations60
US12012420B2Jun 18, 2024

Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate

HOFFMANN LA ROCHE0 citations60
US7409041B2Aug 5, 2008

Methods of transmission mode X-ray diffraction analysis and apparatuses therefor

HOFFMANN LA ROCHE4 citations60
US12459947B2Nov 4, 2025

Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crystalline forms thereof

HOFFMANN LA ROCHE0 citations59
US12122789B2Oct 22, 2024

Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making

HOFFMANN LA ROCHE0 citations54
US10919041B2Feb 16, 2021

Preparing and analyzing solid form properties of a substance

HOFFMANN LA ROCHE0 citations53
US9562009B2Feb 7, 2017

Process to manufacture N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]acetamide

HOFFMANN LA ROCHE0 citations51
US7867452B2Jan 11, 2011

Multi-well filtration device

HOFFMANN LA ROCHE1 citations49
US10227298B2Mar 12, 2019

Solid forms of a pharmaceutically active compound

HOFFMANN LA ROCHE0 citations48
US8975397B2Mar 10, 2015

Solid forms

HOFFMANN LA ROCHE0 citations47
US8785435B2Jul 22, 2014

Solid forms

HOFFMANN LA ROCHE0 citations47
US7160881B2Jan 9, 2007

Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 λ6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide

HOFFMANN LA ROCHE0 citations47
US7772264B2Aug 10, 2010

Salt and polymorphs of a DPPIV inhibitor

HOFFMANN LA ROCHE0 citations46
US8039473B2Oct 18, 2011

Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone

HOFFMANN LA ROCHE1 citations43

RIVER 3 RENAL CORP

2 patents

IBRAHIM PRABHA N

1 patent

ORYZON GENOMICS SA

1 patent